Respiratory Infection
Clinical research includes ventilator-associated pneumonia, with attention to treatment options for critically ill adults and infection control in intensive care settings.
- Ventilator-associated pneumonia
- Antibacterial therapy
- Critical care infection management
Work in this area reflects interest in therapies aimed at difficult-to-treat respiratory bacterial infections.
Diabetic Foot Infection and Wound Care
The sponsor is active in studies of diabetic foot ulcers complicated by Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus, with emphasis on infection resolution and wound recovery.
- Diabetic foot infection
- Ulcer healing
- Multidrug-resistant bacterial pathogens
These trials focus on local treatment strategies for infected chronic wounds in diabetes.
Spinal Cord Injury
Research activity also covers early acute spinal cord injury, with clinical interest in neurological recovery and functional outcomes after recent trauma.
- Acute spinal cord injury
- Neurological impairment
- Motor and sensory function
This area addresses interventions intended for the early treatment of spinal trauma and associated neurological deficits.
Bacteriophage-Based Therapeutics
The sponsor’s portfolio includes therapies built around bacteriophage technology, applied across bacterial infections affecting the lung, skin, and soft tissue.
- Targeted anti-infective therapy
- Phage-based treatment
- Infection-specific biologic approaches
These programs align with clinical interest in infection-focused biologics for hospital-acquired and chronic wound infections.
